Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
about
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.Disparities between male and female patients with thyroid cancers: sex difference or gender divide?Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an updateMedullary thyroid cancer: monitoring and therapy.RET mutations in a large indian family with medullary thyroid carcinoma.Cabozantinib in progressive medullary thyroid cancer.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions.Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatmentDiagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Treating medullary thyroid cancer in the age of targeted therapy.Medullary thyroid carcinoma: The third most common thyroid cancer reviewedGlucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.Improvement of radioimmunotherapy using pretargeting.New developments in the diagnosis and treatment of thyroid cancer.Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer.Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.Sporadic and familial medullary thyroid carcinoma: state of the art.Medullary thyroid carcinoma with micronodular lung metastases: a case report with an emphasis on the imaging findings.Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma.Thyroid safety in patients treated with liraglutide.Hereditary thyroid cancer syndromes and genetic testing.Management of retropharyngeal node metastases from thyroid carcinoma.Surgery for lymph node metastases of medullary thyroid carcinoma: A review.Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).Management of hereditary medullary thyroid carcinoma.Surgical management of medullary thyroid carcinoma.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.Postoperative follow up in patients showing no evident residual disease - cut-offs for imaging/ intervention.Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.Is intraoperative calcitonin monitoring useful to modulate the extension of neck dissection in patients with medullary thyroid carcinoma?Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations.Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.Hereditary and familial thyroid tumours.Targeted Therapy for Medullary Thyroid Cancer: A Review.Medullary thyroid carcinoma - Adverse events during systemic treatment: risk-benefit ratio.Biochemical Testing in Thyroid Disorders.
P2860
Q30317867-60C21999-AF6B-42FC-889A-D6A196283398Q30319959-C2D6F120-D072-4548-8FE5-AC7090FA13FAQ33587821-9CD265EE-2765-4676-9E37-9436DD7E2D19Q33591999-6853CCCB-880D-470B-91AC-CF3BC16DC611Q34069272-226987F6-BA71-4FFC-A552-2C618C778007Q34185084-5D612EDF-FB72-4826-8779-19D3D4329EDEQ34468665-3270DD71-FC0C-4115-A497-FF68EEF167C9Q34628424-04FBE708-59DC-493A-A993-765390FC9B6AQ34894198-835F11C7-26F7-4307-8108-D8AF78C1097FQ35396089-BC890F5C-1D07-4574-AFC5-DEC6B13803F2Q35509932-FEDBD269-7308-409C-AD30-1894AE03A0DFQ36142421-9CEE1F24-81F8-41A9-B773-94BA72B82118Q36765871-BC32E03D-43E8-4454-9F15-879DC529CD79Q36941931-0FBBE636-E5D7-4C09-BD83-8A4C1E005D86Q37238757-2658178A-C702-4DF5-9655-0A1B27E6F37BQ37401654-924F3B70-B049-4447-9829-B54F01DB9D09Q37431034-F191513B-B0E9-4C78-96F4-5734B4F60A33Q37483180-970AD0A6-67C9-4B1B-8395-4A227258FCA2Q37616485-5E4371A2-2283-479A-AF40-DD6F8DC4E07BQ37758299-29647426-1C46-4F03-95E3-6C0ED54C90B2Q37891918-BEA17DBE-249D-467A-AD80-093C6F7E150FQ38088551-04D34A85-4D10-4958-BC46-C63652D21109Q38263389-0647BA24-3813-47DF-8995-2F190232F9B9Q38317141-33213F70-17A6-4020-A11D-E00E8268D4DDQ38625926-670A7DB9-3808-4F6E-A0D9-D77A03E74F86Q38674597-C915D2B5-8CFA-4406-992D-A1D0C11531F2Q38721033-7ED68059-BB9C-48BC-8C03-D5C7543C8CEFQ38837195-8EBD9C99-5539-4EFC-8F53-72889A8E411FQ39002421-6978E952-A6A7-4AB7-8960-A753ACDDA952Q40736049-D8C1F95E-F409-4069-8B53-0BC34F530AEFQ41043862-4828427C-2B8E-437D-83A2-681E7F04A219Q41412595-607165A4-CEFE-45CA-B4E7-5A7E08E5F3E3Q42449414-949E9D70-7401-4070-8D49-5D3EF4C75372Q42451326-13EC23FE-12CD-4EF2-81C7-B9B8CCCAE09DQ42491619-60CEB409-E757-41F3-8BC5-41E3C985380EQ44194816-C55108AB-C938-4366-8198-F7E5A09F5351Q48120117-E8EDC79F-96EB-4ECE-ABE3-942B7552A265Q49328959-F4C9D1D4-F4BC-47E2-97B8-D8F4D07C70A1Q50918579-CA8B6706-40D8-488A-9535-E1F306599404Q55164859-6C8052ED-E9A5-4D3F-9716-1F3973CB8881
P2860
Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prospects of remission in medu ...... ing to basal calcitonin level.
@ast
Prospects of remission in medu ...... ing to basal calcitonin level.
@en
type
label
Prospects of remission in medu ...... ing to basal calcitonin level.
@ast
Prospects of remission in medu ...... ing to basal calcitonin level.
@en
prefLabel
Prospects of remission in medu ...... ing to basal calcitonin level.
@ast
Prospects of remission in medu ...... ing to basal calcitonin level.
@en
P356
P1476
Prospects of remission in medu ...... ing to basal calcitonin level.
@en
P2093
Andreas Machens
Ulrich Schneyer
P304
P356
10.1210/JC.2004-1836
P407
P577
2005-01-05T00:00:00Z